Patents Assigned to Zenvision Pharma LLP
  • Patent number: 11377445
    Abstract: The present disclosure relates to novel hydroxyl or halogen substituted derivatives of C11-C22 alkanoic acid ester of Paliperidone compound of formula (formula II) and process for preparing the same. The said compounds used in pharmaceutical composition for the treatment of schizophrenia and schizoaffective disorder, wherein, R?C10-C21 alkyl substituted by hydroxy or halogen.
    Type: Grant
    Filed: November 23, 2018
    Date of Patent: July 5, 2022
    Assignee: Zenvision Pharma LLP
    Inventors: Sivakumar Venkata Bobba, Eswar Rao Kodali